Fri, March 13, 2020

Mayank Mamtani Maintained (XFOR) at Strong Buy with Decreased Target to $19 on, Mar 13th, 2020

Mayank Mamtani of B. Riley Securities, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $25 to $19 on, Mar 13th, 2020.

Mayank has made no other calls on XFOR in the last 4 months.



There are 3 other peers that have a rating on XFOR. Out of the 3 peers that are also analyzing XFOR, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mayank


  • Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $22 on, Tuesday, January 7th, 2020
  • Zegbeh Jallah of "Roth Capital" Initiated at Strong Buy and Held Target at $20 on, Wednesday, December 18th, 2019
  • Joel Beatty of "Citigroup" Upgraded from Hold to Strong Buy on, Monday, December 9th, 2019